I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bang, Yung-Jue
968
results:
Search for persons
X
Format
Online (968)
Mediatypes
E-Books (1)
Articles (Online) (328)
Bookchapter (Online) (4)
OpenAccess-fulltext (635)
Languages
english (512)
Sorted by: Relevance
Sorted by: Year
?
1
A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovor..:
Lee, Keun-Wook
;
Han, Sae-Won
;
Kim, Tae Won
...
Cancer Research and Treatment. 56 (2024) 2 - p. 590-601 , 2024
Link:
https://doi.org/10.4143/..
?
2
Zolbetuximab plus chemotherapy for locally advanced unresec..:
Shitara, Kohei
;
Shah, Manish A.
;
Lordick, Florian
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
3
Trastuzumab deruxtecan in HER2-positive advanced gastric ca..:
Shitara, Kohei
;
Bang, Yung-Jue
;
Iwasa, Satoru
...
Nature Medicine. 30 (2024) 7 - p. 1933-1942 , 2024
Link:
https://doi.org/10.1038/..
?
4
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in..:
Shitara, Kohei
;
Rha, Sun Young
;
Wyrwicz, Lucjan S
...
The Lancet Oncology. 25 (2024) 2 - p. 212-224 , 2024
Link:
https://doi.org/10.1016/..
?
5
Trastuzumab deruxtecan in patients with human epidermal gro..:
Takahashi, Shunji
;
Bando, Hideaki
;
Kinoshita, Ichiro
...
Japanese Journal of Clinical Oncology. 54 (2024) 4 - p. 434-443 , 2024
Link:
https://doi.org/10.1093/..
?
6
Inflamed immune phenotype predicts favorable clinical outco..:
Shen, Jeanne
;
Choi, Yoon-La
;
Lee, Taebum
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e008339 , 2024
Link:
https://doi.org/10.1136/..
?
7
Paclitaxel therapeutic drug monitoring - International asso..:
Hertz, Daniel L.
;
Joerger, Markus
;
Bang, Yung-Jue
...
European Journal of Cancer. 202 (2024) - p. 114024 , 2024
Link:
https://doi.org/10.1016/..
?
8
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positi..:
Shitara, Kohei
;
Lordick, Florian
;
Bang, Yung-Jue
...
The Lancet. 401 (2023) 10389 - p. 1655-1668 , 2023
Link:
https://doi.org/10.1016/..
?
9
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancer..:
Subbiah, Vivek
;
Kreitman, Robert J.
;
Wainberg, Zev A.
...
Nature Medicine. 29 (2023) 5 - p. 1103-1112 , 2023
Link:
https://doi.org/10.1038/..
?
10
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gas..:
Shah, Manish A.
;
Shitara, Kohei
;
Ajani, Jaffer A.
...
Nature Medicine. 29 (2023) 8 - p. 2133-2141 , 2023
Link:
https://doi.org/10.1038/..
?
11
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Pati..:
Klempner, Samuel J.
;
Lee, Keun-Wook
;
Shitara, Kohei
...
Clinical Cancer Research. 29 (2023) 19 - p. 3882-3891 , 2023
Link:
https://doi.org/10.1158/..
?
12
INTEGRATE II: randomised phase III controlled trials of reg..:
Lam, Lyn Ley
;
Pavlakis, Nick
;
Shitara, Kohei
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
13
Tusamitamab Ravtansine in Patients with Advanced Solid Tumo..:
Tabernero, Josep
;
Bedard, Philippe L.
;
Bang, Yung-Jue
...
Cancer Research Communications. 3 (2023) 8 - p. 1662-1671 , 2023
Link:
https://doi.org/10.1158/..
?
14
Randomized, Double-Blind, Placebo-Controlled Phase III Stud..:
Shah, Manish A.
;
Shitara, Kohei
;
Lordick, Florian
...
Clinical Cancer Research. 28 (2022) 17 - p. 3686-3694 , 2022
Link:
https://doi.org/10.1158/..
?
15
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 i..:
Kim, Tae Won
;
Burris III, Howard A.
;
de Miguel Luken, Maria J.
...
Clinical Cancer Research. 28 (2022) 16 - p. 3452-3463 , 2022
Link:
https://doi.org/10.1158/..
1-15